These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9105396)

  • 1. Acquisition of taxol resistance via P-glycoprotein- and non-P-glycoprotein-mediated mechanisms in human ovarian carcinoma cells.
    Parekh H; Wiesen K; Simpkins H
    Biochem Pharmacol; 1997 Feb; 53(4):461-70. PubMed ID: 9105396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug resistance phenotype and paclitaxel (Taxol) sensitivity in human renal carcinoma cell lines of different histologic types.
    Reinecke P; Schmitz M; Schneider EM; Gabbert HE; Gerharz CD
    Cancer Invest; 2000; 18(7):614-25. PubMed ID: 11036469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol).
    Dumontet C; Duran GE; Steger KA; Beketic-Oreskovic L; Sikic BI
    Cancer Res; 1996 Mar; 56(5):1091-7. PubMed ID: 8640766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line.
    Wang NN; Zhao LJ; Wu LN; He MF; Qu JW; Zhao YB; Zhao WZ; Li JS; Wang JH
    Asian Pac J Cancer Prev; 2013; 14(9):4983-8. PubMed ID: 24175763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.
    Kavallaris M; Kuo DY; Burkhart CA; Regl DL; Norris MD; Haber M; Horwitz SB
    J Clin Invest; 1997 Sep; 100(5):1282-93. PubMed ID: 9276747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of cisplatin sensitivity by taxol in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.
    Yamamoto K; Kikuchi Y; Kudoh K; Nagata I
    J Cancer Res Clin Oncol; 2000 Mar; 126(3):168-72. PubMed ID: 10741911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of thymidine phosphorylase expression by Taxol does not enhance Furtulon sensitivity in a cisplatin-resistant human ovarian carcinoma cell line.
    Hata K; Osaki M; Kanasaki H; Nakayama K; Fujiwaki R; Ito H; Miyazaki K
    Anticancer Res; 2003; 23(2B):1525-31. PubMed ID: 12820419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.
    Kelland LR; Abel G
    Cancer Chemother Pharmacol; 1992; 30(6):444-50. PubMed ID: 1356649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taxol Analogues Exhibit Differential Effects on Photoaffinity Labeling of β-Tubulin and the Multidrug Resistance Associated P-Glycoprotein.
    Yang CH; Wang C; Ojima I; Horwitz SB
    J Nat Prod; 2018 Mar; 81(3):600-606. PubMed ID: 29517223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression.
    Chao CC
    FEBS Lett; 1995 Oct; 373(3):285-90. PubMed ID: 7589484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug resistance in androgen-independent growing rat prostate carcinoma cells is mediated by P-glycoprotein.
    Siegsmund MJ; Kreukler C; Steidler A; Nebe T; Köhrmann KU; Alken P
    Urol Res; 1997; 25(1):35-41. PubMed ID: 9079744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
    Kumar A; Soprano DR; Parekh HK
    Cancer Res; 2001 Oct; 61(20):7552-5. PubMed ID: 11606393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublines in vitro.
    Hill BT; Whelan RD; Shellard SA; McClean S; Hosking LK
    Invest New Drugs; 1994; 12(3):169-82. PubMed ID: 7896535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
    Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
    Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Messenger RNA expression of resistance proteins and related factors in human ovarian carcinoma cell lines resistant to doxorubicin, taxol and cisplatin.
    Masanek U; Stammler G; Volm M
    Anticancer Drugs; 1997 Feb; 8(2):189-98. PubMed ID: 9073315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells.
    Kowalski RJ; Giannakakou P; Gunasekera SP; Longley RE; Day BW; Hamel E
    Mol Pharmacol; 1997 Oct; 52(4):613-22. PubMed ID: 9380024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells.
    Yang CP; Galbiati F; Volonte D; Horwitz SB; Lisanti MP
    FEBS Lett; 1998 Nov; 439(3):368-72. PubMed ID: 9845355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a taxol-resistant human small-cell lung cancer cell line.
    Ohta S; Nishio K; Kubota N; Ohmori T; Funayama Y; Ohira T; Nakajima H; Adachi M; Saijo N
    Jpn J Cancer Res; 1994 Mar; 85(3):290-7. PubMed ID: 7514586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species-specific differences in taxol transport and cytotoxicity against human and rodent tumor cells. Evidence for an alternate transport system.
    Parekh H; Simpkins H
    Biochem Pharmacol; 1996 Feb; 51(3):301-11. PubMed ID: 8573197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR4 and NFκB signaling is critical for taxol resistance in ovarian carcinoma cells.
    Sun NK; Huang SL; Chang TC; Chao CC
    J Cell Physiol; 2018 Mar; 233(3):2489-2501. PubMed ID: 28771725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.